SEMAGLUTIDE

Semaglutide is a once-weekly injectable available for the chronic management of obesity. It mimics your body’s own natural appetite-suppressing hormone and improves your ability to regulate blood sugar levels. It helps with weight loss by reducing hunger and stabilizing blood sugar.

1. 15% average weight loss in patients treated with Semaglutide along with behavioral intervention.

2. Sugar control and risk for heart disease was dramatically improved in the patients who lost about 10% of body weight with Semaglutide.

3. Unlike other anti-obesity medications, there was no plateau phase after 28 weeks of treatment. Weight loss with Semaglutide treated arm continued until the end of 68 weeks trial.

4. 1/3 of the participants lost about 20% of the bodyweight which is almost comparable to that of bariatric surgery.

At BayouMD we know obesity and metabolic disorders are complicated. So a simple “eat less, work more” will not be sufficient to treat a disease with genetic, metabolic, psychological, social, and iatrogenic factors.  Meet with our board certified obesity medicine physicians monthly. Receive an individualized diet and exercise regimen as well as weekly semaglutide injections and supplies.